What does 23VPPV mean in VACCINE
23vPPV stands for 23 valent pneumococcal polysaccharide vaccine. It is a type of vaccine used to protect against Streptococcus pneumoniae, which is a bacteria that can cause serious infections that can lead to long-term disability or even death. The 23vPPV vaccine is given to people in order to help prevent such illnesses and keep them healthy.
23vPPV meaning in Vaccine in Medical
23vPPV mostly used in an acronym Vaccine in Category Medical that means 23 valent pneumococcal polysaccharide vaccine
Shorthand: 23vPPV,
Full Form: 23 valent pneumococcal polysaccharide vaccine
For more information of "23 valent pneumococcal polysaccharide vaccine", see the section below.
Essential Questions and Answers on 23 valent pneumococcal polysaccharide vaccine in "MEDICAL»VACCINE"
What is the 23vPPV vaccine?
The 23vPPV vaccine is a type of vaccine used to protect against Streptococcus pneumoniae, which is a bacteria that can cause serious infections that can lead to long-term disability or even death.
Who should get the 23vPPV vaccine?
The Centers for Disease Control and Prevention (CDC) recommend the 23vPPV vaccine be given routinely to all adults 65 years of age and older, as well as certain adults younger than 65 who are at increased risk of pneumococcal disease due to other health conditions.
How often should it be given?
According to the CDC, one dose of the 23vPPV should be given initially and then another dose should be given 5 years later if you have not had any other types of pneumococcal vaccines before. If you have had other types of pneumococcal vaccines before, then it does not need to be repeated as often.
Are there any side effects from taking this vaccine?
Generally speaking, common side effects from taking this vaccine include redness or pain on the injection site, headaches, tiredness, body aches, nausea, and fever. However, these side effects should go away after a few days with no lasting harm.
How well does this vaccine work?
Research shows that this particular type of vaccine provides protection against 85%-90% of strains known to cause pneumococcal diseases in adults aged 65 and over. It also provides greater protection among younger adults who are at increased risk due to existing medical conditions.
Final Words:
In conclusion, the 23 valent pneumococcal polysaccharide vaccine (23vPPV) has been developed in order to help protect people from serious illnesses caused by Streptoccocus pneumoniae bacteria. It is recommended for all adults aged 65 and over as well as those under 65 who have other underlying health conditions according to the CDC guidelines. With its high level of effectiveness in protecting against related illnesses, it is an important part of keeping oneself safe from bacterial infection.